Derbré Séverine, Duval Romain, Roué Gaël, Garofano Aurelio, Poupon Erwan, Brandt Ulrich, Susin Santos A, Hocquemiller Reynald
Laboratoire de Pharmacognosie associé au CNRS (BioCIS, UMR 8076), Université Paris-Sud 11, Centre d'Etudes Pharmaceutiques, 5 rue Jean-Baptiste Clément, 92296 Châtenay-Malabry CEDEX, France.
ChemMedChem. 2006 Jan;1(1):118-29. doi: 10.1002/cmdc.200500011.
Acetogenins of Annonaceae, including squamocin (1), exert spectacular cytotoxicity and the most potent inhibition of NADH:ubiquinone oxidoreductase known so far. Cell death induced by these natural products was identified as apoptosis and was thought to be linked to alterations in mitochondrial function. Quinone-squamocin hybrid compounds were semisynthesized and evaluated for their pro-apoptotic properties with a screening method based on dissipation of the mitochondrial transmembrane potential (DeltaPsim). Herein, we report a short one-step synthesis of a squamocin carboxylic acid analogue. For the first time on a natural product, the radical decarboxylation and quinone addition reaction has enabled preparation of a library of squamocin-quinone hybrids and four other analogues. Squamoquinone, tenfold more potent than squamocin as an inducer of apoptosis, emerged as a promising compound, as it induces apoptosis through a mitochondrial caspase-dependent pathway.